Skip to content

Functional Interest of Non Invasive Brain Stimulation During Physiotherapy at a Subacute Phase Post Stroke (Anodal Protocol): ReSTIM

Functional Interest of Non Invasive Brain Stimulation During Physiotherapy at a Subacute Phase Post Stroke (Anodal Protocol).

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01500564
Acronym
ReSTIM
Enrollment
10
Registered
2011-12-28
Start date
2012-01-02
Completion date
2015-07-31
Last updated
2018-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, transcranial direct current stimulation (tDCS), motor function

Brief summary

Previous research that utilises single sessions of transcranial direct current stimulation (tDCS) have demonstrated functional improvements. However these improvements are usually short-lived, lasting less than one hour before the patient's performance returns to baseline. In these studies, tDCS is typically applied with the goal of adaptively enhancing functional activation of pathologically under-active tissue or suppressing pathologically over-active tissue. Interestingly, a small body of evidence is now emerging to indicate that tDCS can improve learning/memory functions in healthy controls. The goal of this study is to test if the application of tDCS could enhance learning and/or memory for physiotherapy rehabilitation, which may in turn lead to correspondingly greater motor improvement. Patients at a subacute stage (1 to 6 month post stroke) will attend for 10 consecutive daily sessions of tDCS. This research has important implications; previous studies suggest that such an approach has the potential to facilitate physical rehabilitation post-stroke and establish tDCS as a clinically viable rehabilitative tool. Recovery of motor skills may take many months to acquire and therefore strategies that have the potential to enhance acquisition of skill are of practical and scientific interest.

Interventions

DEVICEanodal tDCS (device) Eldith DC-Stimulator

tDCS applied to the motor cortex every day of two consecutive weeks (10 sessions) at 1 mA during 20 minutes. Conductive rubber covered by sponges soaked in saline will be used, held in place by a band. The current will be gradually increased over 100 seconds.

DEVICESham tDCS

Participants will receive sham tDCS over the primary motor cortex of the ipsilesional hemisphere during 20 minutes of motor training (10 consecutive sessions Monday-Friday during two weeks).

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* All subjects must be between the ages of 18-90 and must not be pregnant. * Patients volunteer to participate in the study, with a written informed consent signed * Affiliation to a national health insurance program * First-time clinical ischemic or hemorrhagic cerebrovascular accident - evidenced by a radiological (or physician's) report * Contralesional motor deficit * Lesion sparing primary motor cortex * Stroke onset \>1 month and \<6 months prior to study enrollment

Exclusion criteria

* Coexistent major neurological or psychiatric disease as to decrease number of confounders * History of epilepsy before stroke (or episodes of seizures within the last six months) * Any substantial decrease in alertness, language reception, or attention that might interfere with understanding instructions for motor testing * Subjects with global aphasia and deficits of comprehension * Excessive pain in any joint of the paretic extremity (VAS\>4) * Contraindications to Tdcs : metal in the head, implanted brain medical devices * Coexistent major neurological or psychiatric disease as to decrease number of confounders * A history of significant alcohol or drug abuse in the prior 6 months * Anyone who is currently taking or who has taken anti-malarial treatment in the last 72 hours * Subjects may not have already received constraint induced motor therapy and/or tDCS treatment for stroke * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Fugl Meyer Assessment (Upper extremity) of motor recovery following strokeassessed at one baseline session (day 4), and then again immediately following the last day of the intervention (day 18), 2 weeks (day 32), 1 month, 3 months and 6 months later.Main primary outcome is change in score between the baseline session score and day 32.

Secondary

MeasureTime frameDescription
Motor Activity Log (MAL)assessed at one baseline session (day 4), and then again immediately following the last day of the intervention (day 18), 2 weeks (day 32), 1 month, 3 months and 6 months later.We are looking for a change in scores between the baseline session score, and those collected during each follow-up session.
Jebsen Taylor Hand function test (JTT)assessed at one baseline session (day 4), and then again immediately following the last day of the intervention (day 18), 2 weeks (day 32), 1 month, 3 months and 6 months later.We are looking for a change in scores between the baseline session score, and those collected during each follow-up session.
Functional independence scale (MIF)assessed at one baseline session (day 4), and then again immediately following the last day of the intervention (day 18), 2 weeks (day 32), 1 month, 3 months and 6 months later.We are looking for a change in scores between the baseline session score, and those collected during each follow-up session.
Modified Ashworth Scaleassessed at one baseline session (day 4), and then again immediately following the last day of the intervention (day 18), 2 weeks (day 32), 1 month, 3 months and 6 months later.We are looking for a change in scores between the baseline session score, and those collected during each follow-up session.
Testing motor MRCassessed at one baseline session (day 4), and then again immediately following the last day of the intervention (day 18), 2 weeks (day 32), 1 month, 3 months and 6 months later.We are looking for a change in scores between the baseline session score, and those collected during each follow-up session.
Box and block test (BBT)assessed at one baseline session (day 4), and then again immediately following the last day of the intervention (day 18), 2 weeks (day 32), 1 month, 3 months and 6 months later.We are looking for a change in scores between the baseline session score, and those collected during each follow-up session.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026